Literature DB >> 18679557

Quality of life of children and adolescents from São Paulo: reliability and validity of the Brazilian version of the Pediatric Quality of Life Inventory version 4.0 Generic Core Scales.

Denise A Klatchoian1, Claudio A Len, Maria Teresa R A Terreri, Marina Silva, Caroline Itamoto, Rozana M Ciconelli, James W Varni, Maria Odete E Hilário.   

Abstract

OBJECTIVES: To evaluate the reliability and validity of the Brazilian version of the Pediatric Quality of Life Inventory (PedsQL 4.0) Generic Core Scales and measure the quality of life of healthy children and adolescents and patients with rheumatic diseases.
METHODS: We followed the translation methodology proposed by the developer of the original English version of the PedsQL 4.0. The instrument was administered by interviews in two groups: 240 apparently healthy children and adolescents from São Paulo (SP, Brazil) and 105 patients with chronic rheumatic diseases matched by age, as well as their respective parents or caregivers. The parent proxy-report was administered to the children's parents or caregivers separately on the same day.
RESULTS: Cronbach's alpha values were between 0.6 and 0.9 for all dimensions, demonstrating adequate internal consistency. Patients with rheumatic diseases reported significantly lower PedsQL scores on all dimensions when compared to the healthy control group (p < 0.0001). Construct validity of the Brazilian Portuguese version of the PedsQL 4.0 was also confirmed. Parent proxy-report of patients with rheumatic diseases highly correlated with child self-report for physical functioning (r = 0.77, p < 0.001) and school functioning (r = 0.73, p < 0.001). Lower correlations were observed for emotional and social functioning (r = 0.40 and 0.59, respectively, p < 0.001).
CONCLUSIONS: The tool demonstrated reliability, validity, and the administration was fast and easy. Quality of life in patients with rheumatic diseases was significantly lower than in the healthy control group, supporting the necessity of a comprehensive approach to rheumatic disease management, focused on the psychosocial dimensions.

Entities:  

Mesh:

Year:  2008        PMID: 18679557     DOI: 10.2223/JPED.1788

Source DB:  PubMed          Journal:  J Pediatr (Rio J)        ISSN: 0021-7557            Impact factor:   2.197


  53 in total

1.  Impact of a multidisciplinary evaluation in pediatric patients with nocturnal monosymptomatic enuresis.

Authors:  Simone Nascimento Fagundes; Leticia Azevedo Soster; Adrienne Surri Lebl; Rita Pavione Rodrigues Pereira; Clarice Tanaka; Rodrigo Fernando Pereira; Edwiges Ferreira de Mattos Silvares; Vera H Koch
Journal:  Pediatr Nephrol       Date:  2016-02-25       Impact factor: 3.714

2.  Monosymptomatic nocturnal enuresis in pediatric patients: multidisciplinary assessment and effects of therapeutic intervention.

Authors:  Simone N Fagundes; Adrienne Surri Lebl; Leticia Azevedo Soster; Guilherme Jorge Sousa E Silva; Edwiges Ferreira de Mattos Silvares; Vera H Koch
Journal:  Pediatr Nephrol       Date:  2016-12-17       Impact factor: 3.714

3.  Augmentation index, a predictor of cardiovascular events, is increased in children and adolescents with primary nephrotic syndrome.

Authors:  Cláudia Alves; José Felippe Pinho; Luzia Maria Dos Santos; Giselle Magalhães; Júnia Maria da Silva; Fernanda Luiza Fontes; Sordaini Maria Caligiorne; Sérgio Pinheiro; Maria Glória Rodrigues-Machado
Journal:  Pediatr Nephrol       Date:  2019-12-16       Impact factor: 3.714

4.  Impact of the Bowel Management Program on the quality of life in children with fecal incontinence.

Authors:  João H F Colares; Marionescu Purcaru; Guilherme P F da Silva; Mirna A Frota; Carlos A B da Silva; Antônio A Melo-Filho; Andrea Bischoff; Alberto Peña
Journal:  Pediatr Surg Int       Date:  2016-02-13       Impact factor: 1.827

5.  Juvenile idiopathic arthritis activity and function ability: deleterious effects in periodontal disease?

Authors:  Camila Pugliese; Roberta T A van der Vinne; Lucia M A Campos; Priscila R Guardieiro; Cynthia Saviolli; Eloisa Bonfá; Rosa M R Pereira; Vilma S Viana; Eduardo F Borba; Clovis A Silva
Journal:  Clin Rheumatol       Date:  2015-12-01       Impact factor: 2.980

6.  Behavioral disorders and low quality of life in children and adolescents with chronic kidney disease.

Authors:  Renata C Marciano; Cristina M Bouissou Soares; José Silvério S Diniz; Eleonora M Lima; Jose Maria P Silva; Monica R Canhestro; Andrea Gazzinelli; Carla Cristina D Melo; Cristiane S Dias; Ana Cristina Simões e Silva; Humberto Correa; Eduardo A Oliveira
Journal:  Pediatr Nephrol       Date:  2010-11-26       Impact factor: 3.714

7.  Fatigue and health related quality of life in children and adolescents with cancer.

Authors:  Michelle Darezzo Rodrigues Nunes; Eufemia Jacob; Emiliana Omena Bomfim; Luis Carlos Lopes-Junior; Regina Aparecida Garcia de Lima; Milena Floria-Santos; Lucila Castanheira Nascimento
Journal:  Eur J Oncol Nurs       Date:  2017-05-13       Impact factor: 2.398

8.  Building a response criterion for pediatric multidisciplinary obesity intervention success based on combined benefits.

Authors:  Nelson Nardo Junior; Josiane Aparecida Alves Bianchini; Danilo Fernandes da Silva; Zachary M Ferraro; Carlos Andres Lopera; Vanessa Drieli Seron Antonini
Journal:  Eur J Pediatr       Date:  2018-03-19       Impact factor: 3.183

9.  Anxiety, depression, resilience and quality of life in children and adolescents with pre-dialysis chronic kidney disease.

Authors:  Janaina Matos Moreira; Cristina Maria Bouissou Morais Soares; Antônio Lúcio Teixeira; Ana Cristina Simões E Silva; Arthur Melo Kummer
Journal:  Pediatr Nephrol       Date:  2015-07-27       Impact factor: 3.714

10.  Fatigue in children with juvenile idiopathic arthritis: reliability of the "Pediatric Quality of Life Inventory-Multidimensional Fatigue Scale".

Authors:  Luciana Tudech S P Paulo; Claudio A Len; Maria Odete E Hilario; Soraya A Pedroso; Maria Sylvia S Vitalle; Maria Teresa Terreri
Journal:  Rheumatol Int       Date:  2014-06-19       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.